Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net loss	$ (1,014,192)	$ (119,443)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation	155,594	398,923
Common stock and stock option based compensation for employees and board of directors	366,727	666,620
Accrued non cash performance bonus fair value adjustment		(388,734)
Acquisition contingent consideration fair value adjustment	33,319	(2,757,530)
Impairment of intangible assets		892,929
Issuance of common stock to vendors		26,936
Amortization of right-of-use assets	95,389	95,727
Changes in operating assets and liabilities:
Accounts receivable	(148,461)	251,407
Deferred costs/contract assets	(149,591)	1,834
Prepaid expenses and other current assets	(38,907)	(56,204)
Other assets	54,246	(1,505)
Accounts payable	39,698	(29,881)
Accrued liabilities	(20,310)	(230,124)
Deferred revenue/contract liabilities	375,070	(257,879)
Lease liabilities	(173,627)	(176,293)
Net cash used in operating activities	(425,045)	(1,683,217)
Cash flow from investing activities:
Purchases of equipment	(9,456)	(7,030)
Net cash used in investing activities	(9,456)	(7,030)
Cash flows provided by financing activities:
Cash provided by financing activities
Net change in cash and cash equivalents	(434,501)	(1,690,247)
Cash and cash equivalents, beginning of year	1,848,295	5,619,083
Cash and cash equivalents, end of period	1,413,794	3,928,836
Non-cash Investing and Financing activities:
Issuance of common stock for satisfaction of contingent liability		127,145
Issuance of common stock for non cash performance bonus		127,145
Lease liabilities arising from right-of-use assets		113,182
Common stock subscription receivable		$ 2,984,001